Marco Sgarbanti

1.3k total citations
38 papers, 976 citations indexed

About

Marco Sgarbanti is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Marco Sgarbanti has authored 38 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 19 papers in Virology and 14 papers in Infectious Diseases. Recurrent topics in Marco Sgarbanti's work include interferon and immune responses (20 papers), HIV Research and Treatment (19 papers) and Immune Cell Function and Interaction (15 papers). Marco Sgarbanti is often cited by papers focused on interferon and immune responses (20 papers), HIV Research and Treatment (19 papers) and Immune Cell Function and Interaction (15 papers). Marco Sgarbanti collaborates with scholars based in Italy, Canada and United States. Marco Sgarbanti's co-authors include Angela Battistini, Giulia Marsili, John Hiscott, Anna Lisa Remoli, Rongtuan Lin, Edvige Perrotti, Yaël Mamane, Alessândra Borsetti, Barbara Ensoli and William J. Harrington and has published in prestigious journals such as The Journal of Experimental Medicine, Bioinformatics and Molecular and Cellular Biology.

In The Last Decade

Marco Sgarbanti

38 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Sgarbanti Italy 20 548 330 251 249 235 38 976
Giovanna Rappocciolo United States 20 484 0.9× 324 1.0× 425 1.7× 382 1.5× 209 0.9× 37 1.0k
Marie-Lise Gougeon France 15 608 1.1× 480 1.5× 387 1.5× 88 0.4× 140 0.6× 21 1.1k
Annie Gosselin Canada 16 750 1.4× 695 2.1× 201 0.8× 69 0.3× 289 1.2× 28 1.2k
Kejun Guo United States 17 399 0.7× 387 1.2× 302 1.2× 96 0.4× 250 1.1× 43 992
Alireza Saeidi Malaysia 15 514 0.9× 110 0.3× 305 1.2× 156 0.6× 188 0.8× 19 869
Erika Schlaepfer Switzerland 19 701 1.3× 593 1.8× 208 0.8× 96 0.4× 236 1.0× 33 1.1k
Jean Marc Jacqué United States 9 442 0.8× 604 1.8× 179 0.7× 66 0.3× 256 1.1× 9 889
Kashif Aziz Khan France 15 238 0.4× 175 0.5× 187 0.7× 90 0.4× 177 0.8× 25 711
Brian Tabb United States 8 461 0.8× 597 1.8× 206 0.8× 71 0.3× 250 1.1× 9 939
Vanessa Sue Wacleche Canada 14 724 1.3× 588 1.8× 187 0.7× 58 0.2× 233 1.0× 17 1.1k

Countries citing papers authored by Marco Sgarbanti

Since Specialization
Citations

This map shows the geographic impact of Marco Sgarbanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Sgarbanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Sgarbanti more than expected).

Fields of papers citing papers by Marco Sgarbanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Sgarbanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Sgarbanti. The network helps show where Marco Sgarbanti may publish in the future.

Co-authorship network of co-authors of Marco Sgarbanti

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Sgarbanti. A scholar is included among the top collaborators of Marco Sgarbanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Sgarbanti. Marco Sgarbanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiscott, John, et al.. (2025). Origin and function of anti-interferon type I viral proteins. Virology. 605. 110456–110456. 1 indexed citations
2.
Sandini, Silvia, et al.. (2024). Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level. Pathogens. 13(5). 349–349. 8 indexed citations
3.
Amendola, Antonello, Giulia Marsili, Valentina Tirelli, et al.. (2023). A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation. Virology. 583. 1–13. 13 indexed citations
4.
Moretti, Sonia, Caterina Fimiani, Lucia Fontanelli Šuleková, et al.. (2021). Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy. Pathogens. 10(11). 1488–1488. 10 indexed citations
5.
Remoli, Anna Lisa, Marco Sgarbanti, Edvige Perrotti, et al.. (2020). IκB kinase-ε-mediated phosphorylation triggers IRF-1 degradation in breast cancer cells. Neoplasia. 22(10). 459–469. 9 indexed citations
6.
7.
Marsili, Giulia, et al.. (2016). IFN Regulatory Factors and Antiviral Innate Immunity: How Viruses Can Get Better. Journal of Interferon & Cytokine Research. 36(7). 414–432. 21 indexed citations
8.
Remoli, Anna Lisa, Giulia Marsili, Edvige Perrotti, et al.. (2016). HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation. mBio. 7(5). 23 indexed citations
9.
Marsili, Giulia, et al.. (2014). Type I IFN – A blunt spear in fighting HIV-1 infection. Cytokine & Growth Factor Reviews. 26(2). 143–158. 25 indexed citations
10.
Perrotti, Edvige, Giulia Marsili, Marco Sgarbanti, et al.. (2013). IRF-7: an Antiviral Factor and Beyond. Future Virology. 8(10). 1007–1020. 3 indexed citations
11.
Marsili, Giulia, Anna Lisa Remoli, Marco Sgarbanti, et al.. (2012). HIV-1, interferon and the interferon regulatory factor system: An interplay between induction, antiviral responses and viral evasion. Cytokine & Growth Factor Reviews. 23(4-5). 255–270. 31 indexed citations
12.
Castaldello, Arianna, Marco Sgarbanti, Giulia Marsili, et al.. (2010). Interferon regulatory factor‐1 acts as a powerful adjuvant in tat DNA based vaccination. Journal of Cellular Physiology. 224(3). 702–709. 26 indexed citations
13.
Ridolfi, Barbara, Marco Sgarbanti, Leonardo Sernicola, et al.. (2009). Generation of a human immunodeficiency virus type 1 chronically infected monkey B cell line expressing low levels of endogenous TRIM5α. Journal of Cellular Physiology. 221(3). 760–765. 1 indexed citations
14.
Sgarbanti, Marco, Giulia Marsili, Anna Lisa Remoli, Roberto Orsatti, & Angela Battistini. (2007). IRF‐7. Annals of the New York Academy of Sciences. 1095(1). 325–333. 25 indexed citations
15.
Sgarbanti, Marco, Meztli Arguello, Benjamin R. tenOever, et al.. (2004). A requirement for NF-κB induction in the production of replication-competent HHV-8 virions. Oncogene. 23(34). 5770–5780. 33 indexed citations
16.
Sgarbanti, Marco, Giulia Marsili, Anna Lisa Remoli, et al.. (2004). Analysis of the Signal Transduction Pathway Leading to Human Immunodeficiency Virus‐1‐Induced Interferon Regulatory Factor‐1 Upregulation. Annals of the New York Academy of Sciences. 1030(1). 187–195. 11 indexed citations
17.
Marsili, Giulia, Alessândra Borsetti, Marco Sgarbanti, et al.. (2003). On the Role of Interferon Regulatory Factors in HIV‐1 Replication. Annals of the New York Academy of Sciences. 1010(1). 29–42. 15 indexed citations
18.
Arguello, Meztli, Marco Sgarbanti, Eduardo Osorio-Hernández, et al.. (2003). Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene. 22(7). 964–973. 44 indexed citations
19.
Battistini, Angela, Giulia Marsili, Marco Sgarbanti, Barbara Ensoli, & John Hiscott. (2002). Review: IRF Regulation of HIV-1 Long Terminal Repeat Activity. Journal of Interferon & Cytokine Research. 22(1). 27–37. 42 indexed citations
20.
Lin, Rongtuan, Pierre Génin, Yaël Mamane, et al.. (2001). HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene. 20(7). 800–811. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna Rappocciolo Breakdown of academic impact, for papers by Marie-Lise Gougeon Breakdown of academic impact, for papers by Annie Gosselin Breakdown of academic impact, for papers by Kejun Guo Breakdown of academic impact, for papers by Alireza Saeidi Breakdown of academic impact, for papers by Erika Schlaepfer Breakdown of academic impact, for papers by Jean Marc Jacqué Breakdown of academic impact, for papers by Kashif Aziz Khan Breakdown of academic impact, for papers by Brian Tabb Breakdown of academic impact, for papers by Vanessa Sue Wacleche
Rankless by CCL
2026